SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
HARTNETT MICHAEL J

(Last) (First) (Middle)
102 WILLENBROCK ROAD
ONE TRIBOLOGY CENTER

(Street)
OXFORD CT 06478

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
RBC Bearings INC [ ROLL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President and CEO
3. Date of Earliest Transaction (Month/Day/Year)
08/29/2019
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/29/2019 M 3,472 A $64.15 398,911(1) D
Common Stock 08/29/2019 S(2) 3,472 D $160.034 395,439(1) D
Common Stock 08/30/2019 M 2,302 A $64.15 397,741(1) D
Common Stock 08/30/2019 S(2) 2,302 D $160.0342 395,439(1) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option to Purchase Common Stock $64.15 08/29/2019 M 3,472 07/01/2019 07/01/2021 Common Stock 3,472 $0 16,528 D
Option to Purchase Common Stock $64.15 08/30/2019 M 2,302 07/01/2019 07/01/2021 Common Stock 2,302 $0 14,226 D
Option to Purchase Common Stock $72.83 07/01/2019(3) 07/01/2022 Common Stock 32,000 32,000 D
Option to Purchase Common Stock $72.94 07/08/2019(4) 07/08/2023 Common Stock 60,000 60,000 D
Option to Purchase Common stock $99.64 06/27/2019(5) 06/27/2024 Common Stock 64,000 64,000 D
Option to Purchase Common Stock $132.12 06/07/2019(6) 06/07/2025 Common Stock 76,000 76,000 D
Option to Purchase Common Stock $143.92 06/03/2020(7) 06/03/2026 Common Stock 76,000 76,000 D
Explanation of Responses:
1. Includes 99,800 shares of restricted stock, which vest according to the following schedule; 13,067 shares vest on 6/27/2020; 34,693 shares 1/2 of which vest on 6/7/2020 and 1/2 vest on 6/7/2021; and 52,040 shares 1/3 of which vest on 6/3/2020, 1/3 vest on 6/3/2021 and 1/3 vest on 6/3/2022.
2. Sold pursuant to a 10b5-1 plan.
3. All these options to purchase Common Stock are exercisable except for 16,000 options that vest ob 7/1/2020.
4. All these options to purchase Common Stock are exercisable except for 40,000 options that are subject to the following vesting schedule - 1/2 vest on 7/8/2020 and 1/2 vest on 7/8/2021.
5. All these options to purchase Common Stock are exercisable except for 48,000 options that are subject to the following vesting schedule - 1/3 vest on 6/27/2020, 1/3 vest on 6/27/2021 and 1/3 vest on 6/27/2022.
6. All these options to purchase Common Stock are exercisable except for 60,800 options that are subject to the following vesting schedule - 1/4 vest on 6/7/2020, 1/4 vest on 6/7/2021, 1/4 vest on 6/7/2022 and 1/4 vest on 6/7/2023.
7. Options to purchase shares of Common Stock are subject to the following vesting schedule - 1/5 vest on 6/3/2020, 1/5 vest on 6/3/2021, 1/5 vest on 6/3/2022, 1/5 vest on 6/3/2023 and 1/5 vest on 6/3/2024.
Remarks:
/s/Joseph Salamunovich/attorney in fact 09/03/2019
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.